Reduced Exposure Study Using the CHTP 1.2 With 5 Days in a Confinement Setting Followed by 85 Days in an Ambulatory Setting.
Clinical trial NCT02641587 · COMPLETED
Trial details
- NCT number
- NCT02641587
- Sponsor
- Philip Morris Products S.A.
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2016-01-01
- Primary completion
- 2016-08-01
- Enrollment
- 121
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.